Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Inherited Metabolic Diseases, |
RCV001375626 | SCV001572549 | likely pathogenic | Severe myoclonic epilepsy in infancy | 2021-04-25 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV003753177 | SCV004492008 | pathogenic | Early infantile epileptic encephalopathy with suppression bursts | 2023-04-18 | criteria provided, single submitter | clinical testing | Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. For these reasons, this variant has been classified as Pathogenic. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SCN1A protein function. ClinVar contains an entry for this variant (Variation ID: 1065177). This missense change has been observed in individual(s) with generalized and focal seizures (Invitae). In at least one individual the variant was observed to be de novo. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces leucine, which is neutral and non-polar, with serine, which is neutral and polar, at codon 373 of the SCN1A protein (p.Leu373Ser). |